Cargando…
Successful Treatment of Atopic Dermatitis with Dupilumab in a Patient with Non-Hodgkin’s Lymphoma
Autores principales: | QIU, YunMi, ALI, Kamran, LOU, HaiYue, SHAN, JingPeng, WU, Liming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593481/ https://www.ncbi.nlm.nih.gov/pubmed/34904683 http://dx.doi.org/10.2340/actadv.v101.224 |
Ejemplares similares
-
Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
por: Shan, Jinpeng, et al.
Publicado: (2022) -
Clearance of Chronic Actinic Dermatitis With Dupilumab Therapy in Chinese Patients: A Case Series
por: Ali, Kamran, et al.
Publicado: (2022) -
Dupilumab-induced Acute Generalized Exanthematous Pustulosis in a 17-year-old Female Chinese Patient with Atopic Dermatitis
por: WU, LiMing, et al.
Publicado: (2022) -
Case report: Dupilumab leads to an increased chance of head and neck Staphylococcus aureus infection in atopic dermatitis patients
por: Chen, Min, et al.
Publicado: (2023) -
Case report: Clinical and histopathological characteristics of psoriasiform erythema and de novo IL-17A cytokines expression on lesioned skin in atopic dermatitis children treated with dupilumab
por: Ali, Kamran, et al.
Publicado: (2022)